1. Home
  2. DOMO vs GNFT Comparison

DOMO vs GNFT Comparison

Compare DOMO & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • GNFT
  • Stock Information
  • Founded
  • DOMO 2010
  • GNFT 1999
  • Country
  • DOMO United States
  • GNFT France
  • Employees
  • DOMO N/A
  • GNFT N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DOMO Technology
  • GNFT Health Care
  • Exchange
  • DOMO Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • DOMO 286.1M
  • GNFT 296.4M
  • IPO Year
  • DOMO 2018
  • GNFT 2019
  • Fundamental
  • Price
  • DOMO $9.53
  • GNFT $4.05
  • Analyst Decision
  • DOMO Hold
  • GNFT Strong Buy
  • Analyst Count
  • DOMO 5
  • GNFT 1
  • Target Price
  • DOMO $9.60
  • GNFT $13.00
  • AVG Volume (30 Days)
  • DOMO 218.8K
  • GNFT 7.6K
  • Earning Date
  • DOMO 12-05-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • DOMO N/A
  • GNFT N/A
  • EPS Growth
  • DOMO N/A
  • GNFT N/A
  • EPS
  • DOMO N/A
  • GNFT 0.47
  • Revenue
  • DOMO $318,369,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • DOMO $0.39
  • GNFT $155.44
  • Revenue Next Year
  • DOMO N/A
  • GNFT N/A
  • P/E Ratio
  • DOMO N/A
  • GNFT $8.62
  • Revenue Growth
  • DOMO 0.19
  • GNFT 175.45
  • 52 Week Low
  • DOMO $6.11
  • GNFT $3.12
  • 52 Week High
  • DOMO $12.23
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 67.52
  • GNFT 25.70
  • Support Level
  • DOMO $9.14
  • GNFT $4.17
  • Resistance Level
  • DOMO $9.76
  • GNFT $4.41
  • Average True Range (ATR)
  • DOMO 0.33
  • GNFT 0.11
  • MACD
  • DOMO 0.02
  • GNFT -0.05
  • Stochastic Oscillator
  • DOMO 84.14
  • GNFT 4.13

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: